Publicaciones en colaboración con investigadores/as de Columbia University Medical Center (14)

2023

  1. Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

    European Journal of Cancer, Vol. 178, pp. 23-33

2022

  1. Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

    Breast Cancer Research and Treatment, Vol. 195, Núm. 2, pp. 127-139

  2. SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice

    Nature Communications, Vol. 13, Núm. 1

  3. Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

    npj Breast Cancer, Vol. 8, Núm. 1

2021

  1. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

    Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156

  2. Sacituzumab govitecan in metastatic triple-negative breast cancer

    New England Journal of Medicine, Vol. 384, Núm. 16, pp. 1529-1541

  3. Selenium and impaired physical function in US and Spanish older adults

    Redox Biology, Vol. 38

2020

  1. #SoMe4Surgery: From inception to impact

    BMJ Innovations, Vol. 6, Núm. 2, pp. 72

  2. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum

    American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 499-513

  3. Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

    JBMR Plus, Vol. 4, Núm. 4

2019

  1. Treatment outcomes of immune-related cutaneous adverse events

    Journal of Clinical Oncology, Vol. 37, Núm. 30, pp. 2746-2758

2013

  1. Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial

    Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649

2012

  1. Molecular and functional interaction between protocadherin-γC5 and GABAA receptors

    Journal of Neuroscience, Vol. 32, Núm. 34, pp. 11780-11797

2011

  1. Comparison of two core biopsy techniques before and after laparoscopic cryoablation of small renal cortical Neoplasms

    Journal of the Society of Laparoendoscopic Surgeons, Vol. 15, Núm. 4, pp. 509-516